AU1189392A - Pharmaceutical agent - Google Patents
Pharmaceutical agentInfo
- Publication number
- AU1189392A AU1189392A AU11893/92A AU1189392A AU1189392A AU 1189392 A AU1189392 A AU 1189392A AU 11893/92 A AU11893/92 A AU 11893/92A AU 1189392 A AU1189392 A AU 1189392A AU 1189392 A AU1189392 A AU 1189392A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919102727A GB9102727D0 (en) | 1991-02-08 | 1991-02-08 | Pharmaceutical agent |
GB9102727 | 1991-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1189392A true AU1189392A (en) | 1992-09-07 |
Family
ID=10689748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11893/92A Abandoned AU1189392A (en) | 1991-02-08 | 1992-02-05 | Pharmaceutical agent |
Country Status (12)
Country | Link |
---|---|
CN (1) | CN1064809A (zh) |
AP (1) | AP9200355A0 (zh) |
AU (1) | AU1189392A (zh) |
CA (1) | CA2060825A1 (zh) |
GB (2) | GB9102727D0 (zh) |
HU (1) | HUT60489A (zh) |
IE (1) | IE920243A1 (zh) |
IL (1) | IL100793A0 (zh) |
MX (1) | MX9200532A (zh) |
PT (1) | PT100097A (zh) |
WO (1) | WO1992013853A1 (zh) |
ZA (1) | ZA92729B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU656454B2 (en) * | 1992-02-14 | 1995-02-02 | E.R. Squibb & Sons, Inc. | Biphenyl-substituted quinoline derivatives |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
EP3239170B1 (en) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
JP6543258B2 (ja) | 2013-09-16 | 2019-07-10 | アストラゼネカ アクチボラグ | 治療用重合性ナノ粒子とそれを作製して使用する方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
AP161A (en) * | 1989-08-11 | 1991-12-20 | Ici Plc | Novel Quinoline derivatives. |
-
1991
- 1991-02-08 GB GB919102727A patent/GB9102727D0/en active Pending
-
1992
- 1992-01-27 IE IE024392A patent/IE920243A1/en unknown
- 1992-01-28 IL IL100793A patent/IL100793A0/xx unknown
- 1992-01-31 ZA ZA92729A patent/ZA92729B/xx unknown
- 1992-02-03 AP APAP/P/1992/000355A patent/AP9200355A0/en unknown
- 1992-02-05 WO PCT/GB1992/000214 patent/WO1992013853A1/en active Application Filing
- 1992-02-05 GB GB9202377A patent/GB2252557A/en not_active Withdrawn
- 1992-02-05 HU HU9200354A patent/HUT60489A/hu unknown
- 1992-02-05 AU AU11893/92A patent/AU1189392A/en not_active Abandoned
- 1992-02-06 PT PT100097A patent/PT100097A/pt not_active Application Discontinuation
- 1992-02-07 MX MX9200532A patent/MX9200532A/es unknown
- 1992-02-07 CA CA002060825A patent/CA2060825A1/en not_active Abandoned
- 1992-02-08 CN CN92101425A patent/CN1064809A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU656454B2 (en) * | 1992-02-14 | 1995-02-02 | E.R. Squibb & Sons, Inc. | Biphenyl-substituted quinoline derivatives |
Also Published As
Publication number | Publication date |
---|---|
IL100793A0 (en) | 1992-09-06 |
IE920243A1 (en) | 1992-08-12 |
PT100097A (pt) | 1993-04-30 |
ZA92729B (en) | 1992-11-25 |
CN1064809A (zh) | 1992-09-30 |
MX9200532A (es) | 1992-08-01 |
GB9102727D0 (en) | 1991-03-27 |
AP9200355A0 (en) | 1993-08-03 |
CA2060825A1 (en) | 1992-08-09 |
HU9200354D0 (en) | 1992-04-28 |
GB9202377D0 (en) | 1992-03-18 |
WO1992013853A1 (en) | 1992-08-20 |
GB2252557A (en) | 1992-08-12 |
HUT60489A (en) | 1992-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU656157B2 (en) | Pharmaceutical agents | |
AU2087992A (en) | Pharmaceutical combination formulation | |
PL304317A1 (en) | Pharmaceutical agent | |
PL304508A1 (en) | Pharmaceutical agent | |
AU3542993A (en) | Pharmaceutical compounds | |
AU1189392A (en) | Pharmaceutical agent | |
AU2392492A (en) | Pharmaceutical composition | |
GB9311030D0 (en) | Pharmaceutical formulations | |
GB9323399D0 (en) | Pharmaceutical formulations | |
AU1500992A (en) | Pharmaceutical compound | |
AU2493792A (en) | Pharmaceutical preparation | |
AU2537992A (en) | Pharmaceutical compositions | |
AU658903B2 (en) | Snake-controlling agent | |
AU1740692A (en) | New medicinal use | |
AU1103092A (en) | Immunopotentiating drug | |
PL297548A1 (en) | Pharmaceutical agent | |
AU7135091A (en) | Pharmaceutical composition | |
AU3528593A (en) | Pharmaceutical composition | |
GB9104124D0 (en) | Pharmaceutical agent | |
GB9104123D0 (en) | Pharmaceutical agent | |
AU8996291A (en) | Pharmaceutical formulations | |
AU673835C (en) | Medicinal composition comprising TCF-II | |
AU6933794A (en) | Pharmaceutical formulations | |
GB9316253D0 (en) | Pharmaceutical formulation | |
GB9315016D0 (en) | Pharmaceutical formulation |